<DOC>
	<DOC>NCT00874406</DOC>
	<brief_summary>The purpose of this study is to investigate whether preoperative TAC is able to improve progression free survival and overall survival in patients receiving liver metastasis resection of colorectal cancer.</brief_summary>
	<brief_title>Preoperative Transhepatic Arterial Chemotherapy (TAC) in the Treatment of Liver Metastasis of Resectable Colorectal Cancer</brief_title>
	<detailed_description>We administered TAC(oxaliplatin,FUDR and MMC) 7 days before liver metastasis resection of colorectal cancer. The study endpoints were progression free survival and overall survival as evaluated by intent-to-treat analysis.</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<criteria>age &lt;= 75 years resectable liver metastasis remnant liver volume &gt;= 70% without other organ metastasis or peritoneum metastasis without contradiction of cardiac and pulmonary diseases age &gt; 75 years unresectable liver metastasis remnant liver volume &lt; 50% with other organ metastasis or peritoneum metastasis with contradiction of cardiac and pulmonary diseases</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>colorectal cancer</keyword>
	<keyword>liver metastasis</keyword>
	<keyword>neoadjuvant chemotherapy</keyword>
</DOC>